339 related articles for article (PubMed ID: 12430363)
1. An Rx for reform: a Medicare prescription drug benefit.
Rak J
Health Matrix Clevel; 2002; 12(2):449-505. PubMed ID: 12430363
[No Abstract] [Full Text] [Related]
2. Eliminating innovation: how price controls limit access.
Ingram J
J Leg Med; 2011 Jan; 32(1):115-28. PubMed ID: 21391059
[No Abstract] [Full Text] [Related]
3. The need for health care reform.
Mossinghoff GJ
Health Syst Rev; 1994; 27(3):5-6. PubMed ID: 10134516
[No Abstract] [Full Text] [Related]
4. Drug card setback highlights need for cost relief.
Gundling RL
Healthc Financ Manage; 2003 Apr; 57(4):50-4. PubMed ID: 12735187
[TBL] [Abstract][Full Text] [Related]
5. An introduction to the Medicare Prescription Drug, Improvement, and Modernization Act of 2003.
Siegel S
Health Care Law Mon; 2004 Jan; ():3-14. PubMed ID: 14750394
[No Abstract] [Full Text] [Related]
6. Medicare prescription drugs and reform: what the new law will mean to gastroenterologists and their patients.
Fise T
Am J Gastroenterol; 2004 May; 99(5):775-6. PubMed ID: 15128335
[No Abstract] [Full Text] [Related]
7. Medicare and prescription drugs: prospects for reform.
Gorin SH
Health Soc Work; 2001 May; 26(2):115-8. PubMed ID: 11378996
[No Abstract] [Full Text] [Related]
8. Medicare drugs.
Poisal JA
Health Care Financ Rev; 2003; 25(2):1-5. PubMed ID: 15124373
[TBL] [Abstract][Full Text] [Related]
9. Prescription drug talk cooled off faster than a Texas thunderstorm.
Levin-Epstein M
Manag Care; 2001 May; 10(5):14-6. PubMed ID: 11392723
[No Abstract] [Full Text] [Related]
10. Affordable prescription drugs--state and federal action.
Ohio Nurses Rev; 2003 Aug; 78(7):4. PubMed ID: 15134064
[No Abstract] [Full Text] [Related]
11. Whose pill is sweetest?
Tumulty K
Time; 2000 Sep; 156(12):29-31. PubMed ID: 11183305
[No Abstract] [Full Text] [Related]
12. States' control of prescription drug spending: a heterogeneous approach.
Morden NE; Sullivan SD
Health Aff (Millwood); 2005; 24(4):1032-8. PubMed ID: 16012143
[TBL] [Abstract][Full Text] [Related]
13. Can price and regulatory controls replace free market competition in the drug industry?
Buc NL; Levitt GM
Healthspan; 1993 Nov; 10(10):30-2. PubMed ID: 10130839
[No Abstract] [Full Text] [Related]
14. Medicare prescription drug/reform act: medicine chest or Pandora's box?
Hager MH
J Am Diet Assoc; 2004 Jun; 104(6):890-1. PubMed ID: 15175585
[No Abstract] [Full Text] [Related]
15. Medicare and the politics of prescription drug pricing.
Oberlander J
N C Med J; 2003; 64(6):303-4. PubMed ID: 14983626
[No Abstract] [Full Text] [Related]
16. The Medicare prescription drug plan: assisting our older patients.
Klein MN
ORL Head Neck Nurs; 2004; 22(4):34-5. PubMed ID: 15617318
[TBL] [Abstract][Full Text] [Related]
17. More than the drug benefit.
Olsen GG
Rehab Manag; 2004 Apr; 17(3):42-4. PubMed ID: 15067925
[No Abstract] [Full Text] [Related]
18. Patient assistance programs: information is not our enemy.
Choudhry NK; Lee JL; Agnew-Blais J; Corcoran C; Shrank WH
Health Aff (Millwood); 2009; 28(3):843-4. PubMed ID: 19414896
[No Abstract] [Full Text] [Related]
19. State initiatives on prescription drugs: creating a more functional market.
Reforming States Group
Health Aff (Millwood); 2003; 22(4):128-36. PubMed ID: 12889760
[TBL] [Abstract][Full Text] [Related]
20. Medicare and prescription drugs.
Iglehart JK
N Engl J Med; 2001 Mar; 344(13):1010-5. PubMed ID: 11274630
[No Abstract] [Full Text] [Related]
[Next] [New Search]
